Sunshine Biopharm…
USUSDSunshine Biopharma Inc (US:SBFM) — Biotechnology: Pharmaceutical Preparations. Liczba giełd, na których notowane są akcje spółki: 1. Na tej stronie — cena i wykres, dywidendy, najwięksi akcjonariusze oraz historia liczby akcji.
O Firmie
- Strona
- sunshinebiopharma.com
- Sektor
- Health Care · Biotechnology: Pharmaceutical Preparations
- Siedziba
- FORT LAUDERDALE, United States
- Prezes
- Steve N. Slilaty
- Pracownicy
- 50
- Akcje w Obrocie
- 3.88 mln na 2026-08-13
- Free Float
- 3.81 mln
- Kapitalizacja Rynkowa
- 2.58 mln USD
- Insiderzy
- 1.59%
- Inwestorzy Instytucjonalni
- 6.42%
- Branża (SIC)
- Pharmaceutical Preparations
- P/E
- strata
- FCF
- −5.37 mln USD
- Dług
- 0 USD
- Zyski i FCF — za 12 miesięcy do 30.06.2026 roku (najnowszy raport firmy).
- NAV
Opis
Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, dermatology, smoking cessation, cholelithiasis, anticonvulsant, urology, women's health, acid reflux, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida.
Giełdy i Tickery
| Giełda | Ticker | Waluta | Cena | Typ |
|---|---|---|---|---|
| US USA Stocks | SBFM | USD | 0.23 -5.35% | akcje zwykłe |
Najwięksi Akcjonariusze
| Posiadacz | Udział | Akcje | Data Raportu |
|---|---|---|---|
| NATAN DAVID (Director) | ≈2.58% | 100 000 | 2026-04-14 |
| Jane Street Group, LLC | 0.35% | 14 974 | 2026-06-30 |
| Morgan Stanley | 0.01% | 385 | 2026-06-30 |
| SBI Securities Co., Ltd. | 0% | 162 | 2026-06-30 |
| Fidelity NASDAQ Composit… | 0% | 11 | 2024-08-31 |
| National Bank of Canada/… | 0% | 5 | 2026-06-30 |
| Osaic Holdings Inc. | 0% | 2 | 2026-06-30 |
| Farther Finance Advisors… | 0% | 1 | 2026-06-30 |
| TD Waterhouse Canada Inc… | 0% | 1 | 2026-06-30 |
| Strive Financial Group ,… | 0% | 1 | 2026-06-30 |
| Caitong International As… | 0% | 1 | 2026-06-30 |
